PMID: 2494058Mar 1, 1989Paper

Cyclosporin-A therapy of pure red cell aplasia in a patient with B-cell chronic lymphocytic leukemia

European Journal of Haematology
R ChristenJ Fehr

Abstract

A 65-year-old woman with B-cell chronic lymphocytic leukemia (CLL) and pure red cell aplasia (PRCA) is described. After initial chemotherapy with three different regimens over 3 months (prednisone, chlorambucil/vincristine, cyclophosphamide, bleomycin/cyclophosphamide, etoposide, prednisone), normalization of the blood lymphocyte count was observed, but lymphocyte infiltration of the bone marrow persisted and erythropoiesis remained virtually absent. Monotherapy with cyclosporin-A (CyA) was begun. After 35 days, a marked increase in the reticulocyte count was observed, and with continuing therapy, there was a rapid increase in the hemoglobin level. Follow-up after 13 months of uninterrupted treatment with CyA revealed remission of both CLL and PRCA. CyA should be investigated further as a therapeutic modality for PRCA in patients with CLL, and such trials might provide further clues to the pathogenesis of this peculiar association.

References

Dec 1, 1979·The Journal of Experimental Medicine·J Watson
Feb 1, 1973·The Journal of Clinical Investigation·S B KrantzS D Zaentz
Nov 1, 1973·The American Journal of Medicine·P A Cassileth, A R Myers
May 1, 1981·Scandinavian Journal of Immunology·L Andrus, K J Lafferty
Jun 1, 1981·British Journal of Haematology·E N DessyprisS B Krantz
Jan 1, 1980·Scandinavian Journal of Immunology·F W Symington, H S Teh

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.